Home > News > Study Using Nanogen Assay
June 8th, 2005
Study Using Nanogen Assay
Abstract:
Nanogen, Inc. today announced that a study published in the European Journal of Heart Failure concluded that for patients with severe congestive heart failure, a significantly higher risk of one-year mortality was associated with elevated levels of N-terminal brain natriuretic peptide (NT-proBNP).
Source:
prnewswire
| Related News Press |
Announcements
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026
Tools
Metasurfaces smooth light to boost magnetic sensing precision January 30th, 2026
From sensors to smart systems: the rise of AI-driven photonic noses January 30th, 2026
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||